Business Wire


Del and IndieBio Create Next Generation Innovation Marketplace to Accelerate Early Stage Biotech Research, the world’s largest online marketplace for outsourced research services, and IndieBio, the world’s largest biotech seed accelerator, announced today a partnership to create an innovation marketplace that speeds research and development. Biotech companies participating in IndieBio’s product-directed discovery programs and a long list of accomplished IndieBio alumni can now easily collaborate with over 2,000 commercial research suppliers through the platform.

“Our members have already had success using to quickly find and engage high-quality research suppliers and access new technologies,” said Jun Axup, PhD, IndieBio’s Science Director. “This new partnership with builds off that early success and provides additional benefits to new members as well as our extensive network of alumni companies.”

IndieBio is a venture-backed accelerator in the Bay Area that offers biotech startups the opportunity to transform their business idea into reality with $250K in seed money, operational support and introductions to potential investors and partners. The program accepts fifteen early stage companies twice a year to take part in an intensive four-month business acceleration program.

“Early stage biotech companies, like those at IndieBio, need to be able to find and engage experienced research suppliers quickly,” stated Kevin Lustig, PhD,’s CEO. “IndieBio’s innovation marketplace gives their member companies instant access to our industry-leading supplier network and the sourcing support they need to get high-quality, timely research services at a competitive price.”

Through its partnerships with over half of the major global pharmaceutical companies, handles thousands of outsourcing requests per year, giving it unique insight into the research services market. The new IndieBio innovation marketplace gives its members access to sourcing tools, experience and expertise that would not normally be available to biotech startups.

About is the world’s largest scientific services marketplace. The marketplace simplifies research sourcing, saves time and money and provides access to innovative tools and technologies while maintaining full compliance with an organization’s procurement policies. operates private marketplaces for most leading pharmaceutical companies and the US National Institutes of Health (NIH). Visit to learn more.

About IndieBio

IndieBio is the world’s largest life sciences seed accelerator, with 67 funded startups since March 2015. Companies from all over the world apply to be part of a four-month acceleration program that includes $250,000 in funding, dedicated mentorship and 24/7 access to a co-working space and bio-safety level 1 & 2 research labs. IndieBio companies solve problems in a wide range of industries including biotech, healthcare, agtech, neurotech, regenerative medicine, biomaterials and the future of food among others. Visit to learn more.

Join us on social media: Twitter , Facebook and LinkedIn .

Kevin Lustig



Social Media:

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco